Concentration and timing dependence of lethality enhancement between topotecan, a topoisomerase I inhibitor, and ionizing radiation. [electronic resource]
Producer: 19961120Description: 361-8 p. digitalISSN:- 0360-3016
- Antineoplastic Agents -- administration & dosage
- Camptothecin -- administration & dosage
- Cell Survival -- drug effects
- Combined Modality Therapy
- Fibroblasts -- drug effects
- Humans
- Melanoma
- Neoplasms -- drug therapy
- Radiation Dosage
- Radiation Tolerance -- drug effects
- Time Factors
- Topoisomerase I Inhibitors
- Topotecan
- Tumor Cells, Cultured
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.